Immuneering Corp. (IMRX)
5.65
-0.02
(-0.35%)
USD |
NASDAQ |
Dec 19, 16:00
5.84
+0.19
(+3.36%)
After-Hours: 20:00
Immuneering Shareholders Equity (Annual): 41.39M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 67.09M |
| Regeneron Pharmaceuticals, Inc. | 29.35B |
| Fortress Biotech, Inc. | 22.74M |
| BridgeBio Pharma, Inc. | -1.468B |
| Absci Corp. | 179.13M |